PATRICIA ALLEN: Open Payments
NPI 1598956211 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 21 payments from 8 companies in 2025. Trend: 2023 $356 · 2024 $417 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $141 |
| E.R. Squibb & Sons, L.L.C. | 5 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| Lundbeck LLC | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $15 |
Products named: Auvelity, COBENFY, REXULTI, SPRAVATO, UZEDY, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, Secuado.
Industry payments across TX — which companies pay providers there.
